An Implementation Roadmap to Accelerate Academic Clinical Cancer Research in Portugal: A Multistakeholder Perspective
DOI:
https://doi.org/10.20344/amp.23479Keywords:
Academic Medical Centers, Biomedical Research, Clinical Trials as Topic, Health Policy, Medical Oncology, Neoplasms, Portugal, Research PersonnelAbstract
n/a.
Downloads
References
Leary A, Besse B, André F. The need for pragmatic, affordable, and practice-changing real-life clinical trials in oncology. Lancet. 2024;403:406-8.
Organisation for Economic Co-operation and Development. Tackling the impact of cancer on health, the economy and society. Paris: OECD; 2024.
Autoridade Nacional do Medicamento e Produtos de Saúde IP. Evolução anual (2005 a 2022) – ensaios clínicos ao abrigo da diretiva 2001/20 de 04 de abril. [cited 2024 Nov 09]. Available from: https://www.infarmed.pt/documents/15786/6307769/2005-4T2022_PT/051e8cdc-56a5-5405-7921-c04a3a7b93ff.
Citeline Custom Intelligence. EU Benchmark Clinical Research. 2023. [cited 2025 Mar 20]. Available from: https://dcrfonline.nl/wp-content/uploads/sites/12/2023/12/EU-Benchmark-Clinical-Research.pdf.
Ferreira JP, Leite-Moreira A, Da Costa-Pereira A, Soares AJ, Robalo-Cordeiro C, Jerónimo C, et al. Investigação clínica da iniciativa do investigador em Portugal: identificação de problemas e propostas para melhoria. Acta Med Port. 2023;36:305-8.
Borges-Carneiro F, Torre Souto M, Silva I, Leão Moreira P, Ferraz de Oliveira P, Lopes DJ, et al. Clinical trials in Portugal: past and future. position paper from the colleges of clinical pharmacology and pharmaceutical medicine. Acta Med Port. 2024;37:585-8.
Nilsen P. Making sense of implementation theories, models and frameworks. Implement Sci. 2015;10:1-13.
Flottorp SA, Oxman AD, Krause J, Musila NR, Wensing M, Godycki-Cwirko M, et al. A checklist for identifying determinants of practice: a systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in healthcare professional practice. Implement Sci. 2013;8:1-11.
Belgian Health Care Knowledge Centre (KCE). 2024 - BeNeFIT4: Fourth BeNeFIT call for comparative effectiveness studies with ZonMw. 2024. [cited 2025 Mar 13]. Available from: https://kce.fgov.be/en/kce-trials/calls/2024-benefit4-fourth-benefit-call-for-comparative-effectivenessstudies-with-zonmw.
Roquette C, Crisóstomo S, Milagre T, Ribeiro RS, Pedro AR, Valente A. Patient organisations’ views, motivations and experiences on patient involvement in cancer research: a pilot study in Portugal. BMJ Open. 2024;14:e077444.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Acta Médica Portuguesa

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.

